-
Biological immune cells** are currently internationally recognized as the most promising tumor technology**. In 1992, the US FDA officially passed the issue of biological immunity** as one of the basic ** of cancer, which has been widely used in clinical practice in the United States. In 2000, Dr. Yamazaki et al. reported in The Lancet the results of clinical trials of bioimmune liver cancer, and the results showed that the technology can effectively prevent tumor metastasis and **.
In March 2009, the Ministry of Health of China promulgated the Administrative Measures for the Clinical Application of Medical Technology, which included "autologous immune cell technology" in the third category of technology for management, and medical institutions that have passed the approval can carry out clinical application. In October 2011, French scientist Ralph Steinman won the Nobel Prize in Medicine for "discovering dendritic cells and their role in acquired immunity", marking that biological immunity has become a new type of cancer. At present, there are mature products on the market for tumor immunity**.
Such as DCVAX-L (DC vaccine), Provage (prostate cancer vaccine). On June 27, 2018, JW Therapeutics and its affiliate, Shanghai Mingju Biotech, announced that the National Medical Products Administration (NMPA) approved the IND application of JWCAR029, a CAR-T product of Mingju Biologics. This is the first CD19-targeting CAR-T product approved for IND since the release of the "Technical Guidelines for the Research and Evaluation of Cell** Products" in December 2017 and the era of standardization and normalization of cell**.
-
Healthy, sub-healthy and high-risk groups with neoplastic can all be stored, and the storage of healthy people is to prevent disease, store it in the early stage, and use it when needed in the later stage; Sub-healthy people such as those with low immune system function and imbalance, poor physical fitness, susceptibility to diseases, fatigue syndrome, and those who need to improve their physical condition and delay aging; Tumor genetic screening indicates that people at high risk of mutations, defects, or family tumors need to store immune cells.
-
Immune cells play the following roles:
1. Elimination of pathogens: remove latent viruses, remove microscopic lesions, and prevent repeated infections in the body.
2. Killing tumor cells: broad-spectrum anti-cancer cells, targeted killing tumors, and first-line drugs for future tumors.
3. Immune surveillance: high roll-resistant brightness to identify and monitor cell lesions in vivo to prevent hypersensitivity reactions and prevent graft-versus-host disease.
4. Anti-aging: eliminate apoptotic Changkuan cells, promote the production of new cells, improve energy and physical strength, and delay aging.
It is suggested that the storage institution can be stored if it is conditional, and the storage institution can choose an institution with good reputation, strength and good team service.
-
Hello! Immune cell storage can be used to modulate malignant tumors, restoring, activating, modifying, and expanding stored immune cells and infusing them back into the body when you are unfortunate enough to have cancer. It can remove cancer cells in the body, control the development of cancer, and achieve the purpose of regulating cancer.
2 Slow down aging: Aging is a direct manifestation of the slowdown of human body functions, and it is also a natural link. Immune cells can slow down aging and become a reducer for the human body to become envious.
3. Adjust sub-health: Sub-health is the key point of human health and disease, and it is also a warning signal issued by the body. If you don't pay attention, irreparable health hazards can occur. The reinfusion of immune cells can enhance the immunity in the body and significantly adjust the sub-health.
4. Improve immunity: Experiments have confirmed that if conditions permit, the reinfusion of autologous immune cells can significantly enhance human immunity and prevent cancer and other diseases.
It is better to have a healthy life than to be sick.
Clinical studies have confirmed that the use of patients' immune cells has a role in cancer.
However, when the body's immune cells are also low activity and defective, these immune cells cannot play the role of immune cells when they are healthy, which will reduce the therapeutic effect of immune Fengshimai cells. Therefore, immune cells need to be stored as early as possible.
-
Suitable for the group are:
1. After surgery, the purpose of reducing the risk of the population is to travel relatives.
2. Other ** methods have been used, and patients who want to try immunity ** 3, patients who want to improve immunity during the window period after chemoradiotherapy 4, and patients who can't bear chemotherapy imitation orange.
5. Some healthy people with a history of cancer disease in their families are the most important behaviors for the purpose of prevention.
Differences in the functions of the two types of cells.
Stem cells are the builders: as the body grows, stem cell differentiation provides a steady stream of new cells, increasing the number of cells in our body. >>>More
The immune response caused by tumor antigens is mainly cellular immunity, but it can also cause humoral immunity, but humoral immunity does not play a big role in the anti-tumor process.
When the Chinese kings reached the pinnacle of their lives and everything was under their control, they began to fear death, so they would invest a lot of manpower and material resources in the pursuit of the elixirFor example, Qin Shi Huang sent Xu Fu and thousands of boys and girls to the east to seek the elixir, in order to rely on "external forces" to prolong life, however, Qin Shi Huang may not know that in fact, the human body (stem cells) is the best. >>>More
Typical applications such as radiochemotherapy, physical rays in the medical field.
HIV is a virus with an envelope, and the main structure of the envelope is the phospholipid bilayer, which encapsulates the protein shell of HIV. HIV invades the host cell by fusing its own envelope with the cytoplasmic membrane of the host cell, so that the protein shell enters the host cell along with the genetic material and reverse transcriptase. HIV is released in budding after assembly, and the protein coat is wrapped around a phospholipid bilayer from the host cell, known as the envelope structure, so that new viral particles with infectious power are born. >>>More